BPG is committed to discovery and dissemination of knowledge
Citation
Hong F, Castro M, Linse K. Tumor-specific lytic path “hyperploid progression mediated death”: Resolving side effects through targeting retinoblastoma or p53 mutant. World J Clin Oncol 2020; 11(11): 854-867 [PMID: 33312882 DOI: 10.5306/wjco.v11.i11.854]
Please LOGIN to submit a new comment.